Atopic Dermatitis in America Study

A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population

Zelma C. Chiesa Fuxench, Julie K. Block, Mark Boguniewicz, John Boyle, Luz Fonacier, Joel M. Gelfand, Mitchell H. Grayson, David J. Margolis, Lynda Mitchell, Jonathan I. Silverberg, Lawrence Schwartz, Eric Simpson, Peck Y. Ong

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Population-based estimates on the prevalence of atopic dermatitis in adults vary widely. The objectives of this study were to determine the prevalence of atopic dermatitis in the population of the United States, the distribution of disease severity, and its impact on health-related quality of life. Among 1,278 participating adults, the prevalence (95% confidence interval) of atopic dermatitis was 7.3% (5.9–8.8). Overall, 60.1% (56.1–64.1) of participants were classified as having mild, 28.9% (25.3–32.7) as having moderate, and 11% as having severe (8.6–13.7) disease. Patients with atopic dermatitis and those with more severe disease had higher scores in the dermatology life quality index (mean [standard deviation] for AD patients = 4.71 [6.44] vs. control individuals = 0.97 [2.12]) (P < 0.001) and the hospital anxiety (mean [standard deviation] for AD patients = 7.03 [4.80] vs. control individuals = 4.73 [4.8]) and depression (mean, [standard deviation] for AD patients = 5.83 [4.54] vs. control individuals = 3.62 [3.61]) scales, indicating a worse impact on quality of life and an increased likelihood of anxiety or depression. Based on our prevalence estimates, 16.5 million adults would have a diagnosis of atopic dermatitis, with 6.6 million meeting criteria for moderate to severe disease. Our study confirms the high prevalence and disease burden of atopic dermatitis in this population.

Original languageEnglish (US)
Pages (from-to)583-590
Number of pages8
JournalJournal of Investigative Dermatology
Volume139
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Atopic Dermatitis
Cross-Sectional Studies
Population
Quality of Life
Anxiety
Dermatology
Depression
Health
Confidence Intervals

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Atopic Dermatitis in America Study : A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. / Chiesa Fuxench, Zelma C.; Block, Julie K.; Boguniewicz, Mark; Boyle, John; Fonacier, Luz; Gelfand, Joel M.; Grayson, Mitchell H.; Margolis, David J.; Mitchell, Lynda; Silverberg, Jonathan I.; Schwartz, Lawrence; Simpson, Eric; Ong, Peck Y.

In: Journal of Investigative Dermatology, Vol. 139, No. 3, 01.03.2019, p. 583-590.

Research output: Contribution to journalArticle

Chiesa Fuxench, ZC, Block, JK, Boguniewicz, M, Boyle, J, Fonacier, L, Gelfand, JM, Grayson, MH, Margolis, DJ, Mitchell, L, Silverberg, JI, Schwartz, L, Simpson, E & Ong, PY 2019, 'Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population', Journal of Investigative Dermatology, vol. 139, no. 3, pp. 583-590. https://doi.org/10.1016/j.jid.2018.08.028
Chiesa Fuxench, Zelma C. ; Block, Julie K. ; Boguniewicz, Mark ; Boyle, John ; Fonacier, Luz ; Gelfand, Joel M. ; Grayson, Mitchell H. ; Margolis, David J. ; Mitchell, Lynda ; Silverberg, Jonathan I. ; Schwartz, Lawrence ; Simpson, Eric ; Ong, Peck Y. / Atopic Dermatitis in America Study : A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. In: Journal of Investigative Dermatology. 2019 ; Vol. 139, No. 3. pp. 583-590.
@article{7a7a26270e7e4e26a078275994a326b9,
title = "Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population",
abstract = "Population-based estimates on the prevalence of atopic dermatitis in adults vary widely. The objectives of this study were to determine the prevalence of atopic dermatitis in the population of the United States, the distribution of disease severity, and its impact on health-related quality of life. Among 1,278 participating adults, the prevalence (95{\%} confidence interval) of atopic dermatitis was 7.3{\%} (5.9–8.8). Overall, 60.1{\%} (56.1–64.1) of participants were classified as having mild, 28.9{\%} (25.3–32.7) as having moderate, and 11{\%} as having severe (8.6–13.7) disease. Patients with atopic dermatitis and those with more severe disease had higher scores in the dermatology life quality index (mean [standard deviation] for AD patients = 4.71 [6.44] vs. control individuals = 0.97 [2.12]) (P < 0.001) and the hospital anxiety (mean [standard deviation] for AD patients = 7.03 [4.80] vs. control individuals = 4.73 [4.8]) and depression (mean, [standard deviation] for AD patients = 5.83 [4.54] vs. control individuals = 3.62 [3.61]) scales, indicating a worse impact on quality of life and an increased likelihood of anxiety or depression. Based on our prevalence estimates, 16.5 million adults would have a diagnosis of atopic dermatitis, with 6.6 million meeting criteria for moderate to severe disease. Our study confirms the high prevalence and disease burden of atopic dermatitis in this population.",
author = "{Chiesa Fuxench}, {Zelma C.} and Block, {Julie K.} and Mark Boguniewicz and John Boyle and Luz Fonacier and Gelfand, {Joel M.} and Grayson, {Mitchell H.} and Margolis, {David J.} and Lynda Mitchell and Silverberg, {Jonathan I.} and Lawrence Schwartz and Eric Simpson and Ong, {Peck Y.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jid.2018.08.028",
language = "English (US)",
volume = "139",
pages = "583--590",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Atopic Dermatitis in America Study

T2 - A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population

AU - Chiesa Fuxench, Zelma C.

AU - Block, Julie K.

AU - Boguniewicz, Mark

AU - Boyle, John

AU - Fonacier, Luz

AU - Gelfand, Joel M.

AU - Grayson, Mitchell H.

AU - Margolis, David J.

AU - Mitchell, Lynda

AU - Silverberg, Jonathan I.

AU - Schwartz, Lawrence

AU - Simpson, Eric

AU - Ong, Peck Y.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Population-based estimates on the prevalence of atopic dermatitis in adults vary widely. The objectives of this study were to determine the prevalence of atopic dermatitis in the population of the United States, the distribution of disease severity, and its impact on health-related quality of life. Among 1,278 participating adults, the prevalence (95% confidence interval) of atopic dermatitis was 7.3% (5.9–8.8). Overall, 60.1% (56.1–64.1) of participants were classified as having mild, 28.9% (25.3–32.7) as having moderate, and 11% as having severe (8.6–13.7) disease. Patients with atopic dermatitis and those with more severe disease had higher scores in the dermatology life quality index (mean [standard deviation] for AD patients = 4.71 [6.44] vs. control individuals = 0.97 [2.12]) (P < 0.001) and the hospital anxiety (mean [standard deviation] for AD patients = 7.03 [4.80] vs. control individuals = 4.73 [4.8]) and depression (mean, [standard deviation] for AD patients = 5.83 [4.54] vs. control individuals = 3.62 [3.61]) scales, indicating a worse impact on quality of life and an increased likelihood of anxiety or depression. Based on our prevalence estimates, 16.5 million adults would have a diagnosis of atopic dermatitis, with 6.6 million meeting criteria for moderate to severe disease. Our study confirms the high prevalence and disease burden of atopic dermatitis in this population.

AB - Population-based estimates on the prevalence of atopic dermatitis in adults vary widely. The objectives of this study were to determine the prevalence of atopic dermatitis in the population of the United States, the distribution of disease severity, and its impact on health-related quality of life. Among 1,278 participating adults, the prevalence (95% confidence interval) of atopic dermatitis was 7.3% (5.9–8.8). Overall, 60.1% (56.1–64.1) of participants were classified as having mild, 28.9% (25.3–32.7) as having moderate, and 11% as having severe (8.6–13.7) disease. Patients with atopic dermatitis and those with more severe disease had higher scores in the dermatology life quality index (mean [standard deviation] for AD patients = 4.71 [6.44] vs. control individuals = 0.97 [2.12]) (P < 0.001) and the hospital anxiety (mean [standard deviation] for AD patients = 7.03 [4.80] vs. control individuals = 4.73 [4.8]) and depression (mean, [standard deviation] for AD patients = 5.83 [4.54] vs. control individuals = 3.62 [3.61]) scales, indicating a worse impact on quality of life and an increased likelihood of anxiety or depression. Based on our prevalence estimates, 16.5 million adults would have a diagnosis of atopic dermatitis, with 6.6 million meeting criteria for moderate to severe disease. Our study confirms the high prevalence and disease burden of atopic dermatitis in this population.

UR - http://www.scopus.com/inward/record.url?scp=85061536526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061536526&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2018.08.028

DO - 10.1016/j.jid.2018.08.028

M3 - Article

VL - 139

SP - 583

EP - 590

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 3

ER -